2026 Cyrus P. Zabetian: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	82	16096	15146	8099	7494	225	25145

Overview

Cyrus P. Zabetian is affiliated with the University of Washington in the United States and focuses on research primarily within the field of Medicine. Their academic work spans various subfields, including Neurology, Molecular Biology, Psychiatry and Mental Health, Genetics, and Physiology.

The main topics covered in Zabetian's research include:

Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Dementia and Cognitive Impairment Research
Autism Spectrum Disorder Research
Neurological diseases and metabolism
Neuroinflammation and Neurodegeneration Mechanisms
Genomic variations and chromosomal abnormalities

Zabetian has contributed frequently to several publication venues, notably:

Neurology
bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's & Dementia
npj Parkinson's Disease
Movement Disorders

The scientist has collaborated extensively with a number of coauthors, including:

Joseph F. Quinn
Thomas J. Montine
Brenna Cholerton
Ignácio F. Mata
Dora Yearout

Recent notable papers authored or coauthored by Cyrus P. Zabetian include:

"Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens" published in 2020 in npj Parkinson's Disease
"Characterizing the Genetic Architecture of Parkinson's Disease in Latinos" published in 2021 in Annals of Neurology
"Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau" published in 2020 in Brain
"Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease" published in 2022 in Alzheimer's & Dementia
"Multivariate prediction of dementia in Parkinson's disease" published in 2020 in npj Parkinson's Disease

Best Publications

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz

2380
Citations
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Daniel G Healy;Mario Falchi;Sean S O'Sullivan;Vincenzo Bonifati

1737
Citations
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

Taye H. Hamza;Cyrus P. Zabetian;Cyrus P. Zabetian;Albert Tenesa;Alain Laederach

905
Citations
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

Erin M. Hill-Burns;Justine W. Debelius;James T. Morton;William T. Wissemann

779
Citations
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

Zhen Hong;Min Shi;Kathryn A. Chung;Joseph F. Quinn

728
Citations
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

Min Shi;Changqin Liu;Travis J. Cook;Kristin M. Bullock;Kristin M. Bullock

622
Citations
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database.

Christina M. Lill;Johannes T. Roehr;Johannes T. Roehr;Matthew B. McQueen;Fotini K. Kavvoura;Fotini K. Kavvoura;Fotini K. Kavvoura

598
Citations
Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

573
Citations
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

Min Shi;Joshua Bradner;Aneeka M. Hancock;Kathryn A. Chung

482
Citations
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

Fadi Abdi;Joseph F. Quinn;Joseph Jankovic;Martin McIntosh

478
Citations
APOE ε4 increases risk for dementia in pure synucleinopathies.

Debby Tsuang;James B. Leverenz;Oscar L. Lopez;Ronald L. Hamilton

438
Citations
The Genetics of Parkinson Disease

Lynn M. Bekris;Ignacio F. Mata;Cyrus P. Zabetian

382
Citations
A quantitative-trait analysis of human plasma-dopamine β-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus

Cyrus P. Zabetian;George M. Anderson;Sarah G. Buxbaum;Robert C. Elston

347
Citations
Meta-analysis of Parkinson's Disease: Identification of a Novel Locus, RIT2

Nathan Pankratz;Gary W. Beecham;Anita L. Destefano;Ted M. Dawson

330
Citations
Phosphorylated α-Synuclein in Parkinson’s Disease

Yu Wang;Min Shi;Kathryn A. Chung;Cyrus P. Zabetian

302
Citations
Glucocerebrosidase Gene Mutations: A Risk Factor for Lewy Body Disorders

Ignacio F. Mata;Ali Samii;Seth H. Schneer;John W. Roberts

290
Citations
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

Ivana Devic;HyeJin Hwang;John Scott Edgar;Kenneth Izutsu

261
Citations
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

Ignacio F. Mata;James B. Leverenz;Daniel Weintraub;John Q. Trojanowski

254
Citations
Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee

Taye H. Hamza;Honglei Chen;Erin M. Hill-Burns;Shannon L. Rhodes

251
Citations
Phosphorylated a-Synuclein in Parkinson's Disease

Yu Wang;Min Shi;Kathryn A. Chung;Cyrus P. Zabetian

233
Citations

Frequent Co-Authors

Joseph F. Quinn Oregon Health & Science University

James B. Leverenz Cleveland Clinic

Thomas J. Montine Stanford University

Haydeh Payami University of Alabama at Birmingham

Ali Samii University of Washington

Stewart A. Factor Emory University

Elaine R. Peskind University of Washington

John Q. Trojanowski University of Pennsylvania

Daniel Weintraub University of Pennsylvania

Douglas Galasko University of California, San Diego

External Links

Personal website of Cyrus P. Zabetian

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens a variety of rewarding online degree options and career pathways beyond the traditional MD. For those already licensed as registered nurses, rn to bsn online programs are a popular way to upgrade credentials and broaden job prospects. These flexible programs are designed to fit around busy schedules, making career advancement more accessible.

If you have a non-nursing bachelor’s degree, consider pursuing direct entry msn programs for non nurses online. These innovative tracks can fast-track your entry into advanced nursing roles—even without a prior nursing background.

For those beginning their journey in healthcare, adn programs are among the most accessible ways to become a registered nurse in less time. These associate degree options often have less competitive entry requirements, making them attractive for new students.

Not all medical careers involve direct patient care. Learners interested in healthcare support roles may look into online medical billing and coding schools that accept fafsa. These programs provide practical training for essential administrative positions, with opportunities for federal financial aid to manage costs.